Table 1.
The relationship between miR-133b expression and clinicopathological characterisics of bladder cancer
| Charactistics | n = 41 |
MiR-133b level |
P value | |
|---|---|---|---|---|
| High (%) | Low (%) | |||
|
Gender |
|
|
|
|
| Male |
29 |
11(64.5) |
18(75) |
0.475a |
| Female |
12 |
6(35.3) |
6(25) |
0.187a |
|
Clinical stage |
|
|
|
|
| Ta-T1 (non-invasive) |
24 |
12 |
012 |
|
| T2-T4 (invasive) |
17 |
5 |
12 |
0.003b* |
|
Pathological grading |
|
|
|
|
| Low level |
19 |
13 |
6 |
|
| High level |
21 |
4 |
17 |
|
|
Neoplasm recurrence |
|
|
|
|
| Early-onset |
25 |
10 |
15 |
0.812a |
| Recurrent | 16 | 7 | 9 | |
aChi-square test, bSided Fisher’s exact test, *P < 0.01.